Next Article in Journal
MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis
Next Article in Special Issue
Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020
Previous Article in Journal
Association of Low-Grade Glioma Diagnosis and Management Approach with Mental Health Disorders: A MarketScan Analysis 2005–2014
Previous Article in Special Issue
An Intersectional Perspective on the Utilization of Cervical Cancer Screening among Migrants. A Cross-Sectional Analysis of Survey Data from Austria
 
 
Article

Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial

1
IRD, Ceped (IRD, Université de Paris, Inserm), 75006 Paris, France
2
Ethno Logik, 97435 Saint Gilles les Hauts, La Reunion, France
3
AgroParisTech, 75005 Paris, France
4
Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, Laboratoire ETREs, 75006 Paris, France
5
CIC1432, CHU Dijon-Bourgogne et Université de Bourgogne, 21000 Dijon, France
*
Author to whom correspondence should be addressed.
Academic Editor: Sadeep Shrestha
Cancers 2022, 14(6), 1380; https://doi.org/10.3390/cancers14061380
Received: 16 November 2021 / Revised: 3 March 2022 / Accepted: 4 March 2022 / Published: 8 March 2022
Reunion Island is a French overseas department where cervical cancer is 2 to 3 times more prevalent than in mainland France. Screening rates are lower, especially among women from disadvantaged socioeconomic backgrounds. The RESISTE research program aims to assess whether sending a self-sampling kit to women’s homes could improve screening uptake. Prior to the implementation of this program, qualitative research was conducted with women from various disadvantaged backgrounds, as well as health professionals, to measure knowledge levels, identify barriers and triggers to screening, and assess the acceptability of a home-based self-sampling methodology. The results demonstrate the interest of women and health professionals in this screening method, while also highlighting the need to (1) reassure women regarding usage and quality and (2) provide support and outreach.
Cervical cancer incidence and mortality rates are 2 to 3 times higher in the overseas department of Reunion compared with mainland France. RESISTE’s cluster-randomized controlled trial aims to test the effectiveness of home-based self-sampling (HBSS) through a high-risk oncogenic papillomavirus test sent out by post to women who have not been screened in the past 3 years, despite having been invited to do so through a reminder letter. Prior to the trial, qualitative research was carried out to understand screening barriers and assess anticipated acceptability. Semi-structured interviews were conducted with 35 women and 20 healthcare providers. Providers consider HBSS a viable method in reaching women who tend not to visit a doctor regularly, or who are reluctant to undergo a smear pap, as well as those who are geographically isolated. They considered, however, that women would require support, and that outreach was necessary to ensure more socially isolated women participate. The majority of the women surveyed were in favour of HBSS. However, two-thirds voiced concerns regarding the test’s efficiency and their ability to perform the test correctly, without harming themselves. Based on these findings, recommendations were formulated to reassure women on usage and quality, and to help reach socially isolated women. View Full-Text
Keywords: cervical cancer screening; home-based self-sampling; HPV testing; Reunion Island; socio-economic insecurity; social disadvantage; social isolation; qualitative study cervical cancer screening; home-based self-sampling; HPV testing; Reunion Island; socio-economic insecurity; social disadvantage; social isolation; qualitative study
Show Figures

Figure 1

MDPI and ACS Style

Pourette, D.; Cripps, A.; Guerrien, M.; Desprès, C.; Opigez, E.; Bardou, M.; Dumont, A. Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial. Cancers 2022, 14, 1380. https://doi.org/10.3390/cancers14061380

AMA Style

Pourette D, Cripps A, Guerrien M, Desprès C, Opigez E, Bardou M, Dumont A. Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial. Cancers. 2022; 14(6):1380. https://doi.org/10.3390/cancers14061380

Chicago/Turabian Style

Pourette, Dolorès, Amber Cripps, Margaux Guerrien, Caroline Desprès, Eric Opigez, Marc Bardou, and Alexandre Dumont. 2022. "Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial" Cancers 14, no. 6: 1380. https://doi.org/10.3390/cancers14061380

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop